WallStreetZenWallStreetZen

NASDAQ: CSTL
Castle Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CSTL past revenue growth

How has CSTL's revenue growth performed historically?
Company
60.38%
Industry
0.14%
Market
16.96%
CSTL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CSTL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CSTL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CSTL earnings and revenue history

Current Revenue
$219.8M
Current Earnings
-$57.5M
Current Profit Margin
-26.1%

CSTL Return on Equity

Current Company
-14.9%
Current Industry
-24%
Current Market
188%
CSTL's Return on Equity (-14.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CSTL announces earnings.

CSTL Return on Assets

Current Company
-13.2%
Current Industry
6.7%
CSTL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CSTL Return on Capital Employed

Current Company
-14.14%
Current Industry
11.6%
CSTL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CSTL vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CSTL$219.79M-$45.02M-$57.47M+57.35%N/A
FLGT$289.21M-$134.12M-$167.83M+68.41%N/A
CDNA$280.32M-$182.19M-$190.28M+29.63%N/A
LAB$106.34M-$65.66M-$74.66M-1.20%N/A
SERA$306.00k-$34.76M-$36.24M+70.75%N/A
View Top Diagnostic & Research Stocks

CSTL earnings dates

Next earnings date
May 2, 2024

Castle Biosciences Earnings & Revenue FAQ

What were CSTL's earnings last quarter?

On Invalid Date, Castle Biosciences (NASDAQ: CSTL) reported Q4 2023 earnings per share (EPS) of -$0.09, up 88.61% year over year. Total Castle Biosciences earnings for the quarter were -$2.58 million. In the same quarter last year, Castle Biosciences's earnings per share (EPS) was -$0.79.

If you're new to stock investing, here's how to buy Castle Biosciences stock.

What was CSTL's earnings growth in the past year?

As of Q2 2024, Castle Biosciences's earnings has grown year over year. Castle Biosciences's earnings in the past year totalled -$57.47 million.

What is CSTL's earnings date?

Castle Biosciences's earnings date is Invalid Date. Add CSTL to your watchlist to be reminded of CSTL's next earnings announcement.

What was CSTL's revenue last quarter?

On Invalid Date, Castle Biosciences (NASDAQ: CSTL) reported Q4 2023 revenue of $66.12 million up 72.47% year over year. In the same quarter last year, Castle Biosciences's revenue was $38.34 million.

What was CSTL's revenue growth in the past year?

As of Q2 2024, Castle Biosciences's revenue has grown 60.38% year over year. This is 60.24 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.14%. Castle Biosciences's revenue in the past year totalled $219.79 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.